Showing results (71-80 of 84) with videos related to
Sort By:
Pageof 9
Bulletin Du Cancer|September 30, 1998
[Long-term prognostic role of steroid receptors in cancer of the breast]P Broët, M F Pichon, H Magdelenat, et al.British Journal of Cancer|June 1, 1996
Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancersM F Pichon, P Broet, H Magdelenat, et al.Annales De Biologie Clinique|October 9, 2002
[RNA isolation and purification methods]J P Bastard, S Chambert, F Ceppa, et al.Endocrine-Related Cancer|September 17, 2004
Inter-laboratory quality control for hormone-dependent gene expression in human breast tumors using real-time reverse transcription-polymerase chain reactionP de Cremoux, I Bieche, C Tran-Perennou, et al.British Journal of Cancer|April 25, 2013
Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with trastuzumabM Cizkova, M-E Dujaric, J Lehmann-Che, et al.Journal of Molecular Endocrinology|October 3, 2007
Oligonucleotide microarray analysis of estrogen receptor alpha-positive postmenopausal breast carcinomas: identification of HRPAP20 and TIMELESS as outstanding candidate markers to predict the response to tamoxifenS Tozlu-Kara, V Roux, C Andrieu, et al.Cytometry|July 13, 2001
Optimizing flow cytometric DNA ploidy and S-phase fraction as independent prognostic markers for node-negative breast cancer specimensC B Bagwell, G M Clark, F Spyratos, et al.European Journal of Cancer (Oxford, England : 1990)|January 14, 2009
Methylated genes as new cancer biomarkersM J Duffy, R Napieralski, J W M Martens, et al.Clinics in Laboratory Medicine|January 5, 2002
DNA and cell cycle analysis as prognostic indicators in breast tumors revisitedC B Bagwell, G M Clark, F Spyratos, et al.Breast Cancer Research and Treatment|September 5, 2016
BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapyA S Hamy, I Bieche, J Lehmann-Che, et al.Pageof 9